Direct Oral Anticoagulants Vs Vitamin-K Antagonists In Thrombotic Antiphospholipid Syndrome

Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome

Anticoagulation Forum

Pharmacology: Anticoagulants, Animation

Alila Medical Media

DOACs vs VKAs in thrombotic APS - Dr Jean Connors & Dr Behnood Bikdeli

ThrombosisCanada

Apixaban Versus Heparin/Vitamin K Antagonist in Anticoagulation-naïve Patients with AF

VTE and Anticoagulation - Guideline Updates for 2024

2023 Updates in Anticoagulation

UCSF Department of Medicine

Disadvantages of Novel Oral Anticoagulants Compared with Vitamin K Antagonists

Pharmacy Times TV

Non–Vitamin K Antagonist Oral Anticoagulants helpful in Stroke

Medical Dialogues

Cancer-Associated Thrombosis and Antiphospholipid Syndrome: An Update for Clinicians

AHD Periprocedural Antithrombotic Therapy M Holmberg

UW Internal Medicine Residency

Antiplatelet, Anticoagulant, Thrombolytic Agents

Oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism

Direct oral anticoagulants versus warfarin

ERA - European Renal Association

Oral Anticoagulation in 2024: Lessons from the randomized trials - Grand Rounds

University of Ottawa Heart Institute

Antiphospholipid Syndrome

MedStar Georgetown Department of Medicine

04 Professor Beverley Hunt Anticoagulation Q and A session

Webinar on A Multidisciplinary Approach To The Management Of Anti-phospholipid Syndrome

SuburbanDiagnostics

Advantages of Novel Oral Anticoagulants Over Vitamin K Antagonists

Pharmacy Times TV